Breaking News Instant updates and real-time market news.

CAMP

CalAmp

$14.27 /

+0.57 (+4.16%)

16:11
06/24/21
06/24
16:11
06/24/21
16:11

CalAmp reports Q1 adjusted EPS 8c, consensus 7c

Reports Q1 revenue $80.5M, consensus $80.25M. "We continued to experience strong demand for our products and solutions throughout the quarter, resulting in record Software and Subscription Services revenue and another solid quarter with our largest customer," commented CEO Jeff Gardner. "Our SaaS business is benefiting from a strong recovery from the prior year low-point at the onset of the pandemic, and there are signs of increased business activity not only in the U.S. but also in our targeted geographies around the world in support of customers' 3G-to-4G upgrades. We are cautiously managing through the global component shortages that persist in the supply chain and expect revenue growth to accelerate as the situation normalizes."

  • 24

    Jun

  • 28

    Jul

CAMP CalAmp
$14.27 /

+0.57 (+4.16%)

04/23/21 Canaccord
CalAmp price target raised to $17 from $14 at Canaccord
03/18/21 Canaccord
CalAmp price target raised to $14 from $13 at Canaccord
12/18/20 JPMorgan
CalAmp downgraded to Underweight with $11 target at JPMorgan
12/18/20 JPMorgan
CalAmp downgraded to Underweight from Neutral at JPMorgan

TODAY'S FREE FLY STORIES

Earnings
Parker-Hannifin reports Q4 adjusted EPS $4.38, consensus $4.32 » 07:47
08/05/21
08/05
07:47
08/05/21
07:47
PH

Parker-Hannifin

$303.40 /

-5.96 (-1.93%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PH Parker-Hannifin
$303.40 /

-5.96 (-1.93%)

PH Parker-Hannifin
$303.40 /

-5.96 (-1.93%)

08/03/21 Berenberg
Meggitt downgraded to Hold from Buy at Berenberg
08/02/21 Baird
Baird says Parker-Hannifin paid 'robust' price for Meggitt, has good M&A record
06/23/21
Fly Intel: Top five analyst upgrades
06/23/21 KeyBanc
KeyBanc upgrades Parker-Hannifin to Overweight on 'multiyear upcycle'
PH Parker-Hannifin
$303.40 /

-5.96 (-1.93%)

PH Parker-Hannifin
$303.40 /

-5.96 (-1.93%)

Hot Stocks
Arena Pharmaceuticals, Second Genome enter collaboration » 07:47
08/05/21
08/05
07:47
08/05/21
07:47
ARNA

Arena Pharmaceuticals

$59.38 /

-1.02 (-1.69%)

Second Genome announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$59.38 /

-1.02 (-1.69%)

ARNA Arena Pharmaceuticals
$59.38 /

-1.02 (-1.69%)

05/18/21 Goldman Sachs
Arena Pharmaceuticals initiated with a Buy at Goldman Sachs
04/27/21 Citi
Arena Pharmaceuticals initiated with a Buy at Citi
04/26/21 Credit Suisse
Arena Pharmaceuticals assumed with an Outperform at Credit Suisse
04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
ARNA Arena Pharmaceuticals
$59.38 /

-1.02 (-1.69%)

ARNA Arena Pharmaceuticals
$59.38 /

-1.02 (-1.69%)

Recommendations
Stephens raises Ping Identity price target to $35, names a Best Idea » 07:47
08/05/21
08/05
07:47
08/05/21
07:47
PING

Ping Identity

$22.43 /

+0.44 (+2.00%)

Stephens analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PING Ping Identity
$22.43 /

+0.44 (+2.00%)

PING Ping Identity
$22.43 /

+0.44 (+2.00%)

07/16/21 Mizuho
Ping Identity price target lowered to $29 from $30 at Mizuho
06/11/21 Needham
Needham starts Ping Identity at Hold, sees upside potential 'baked in'
06/11/21 Needham
Ping Identity initiated with a Hold at Needham
05/24/21 Stifel
Ping Identity resumed with a Hold at Stifel
PING Ping Identity
$22.43 /

+0.44 (+2.00%)

  • 10
    Oct
  • 15
    Jun
  • 15
    Dec
PING Ping Identity
$22.43 /

+0.44 (+2.00%)

Recommendations
Verisk Analytics price target raised to $195 from $182 at BMO Capital » 07:47
08/05/21
08/05
07:47
08/05/21
07:47
VRSK

Verisk Analytics

$187.52 /

-0.96 (-0.51%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSK Verisk Analytics
$187.52 /

-0.96 (-0.51%)

VRSK Verisk Analytics
$187.52 /

-0.96 (-0.51%)

07/21/21 Morgan Stanley
Verisk Analytics at good point to add to positions, says Morgan Stanley
07/07/21 RBC Capital
Verisk Analytics assumed with an Outperform at RBC Capital
04/27/21 Jefferies
Verisk could hold strategic review of financial services segment, says Jefferies
03/08/21 Raymond James
Verisk Analytics upgraded to Outperform from Market Perform at Raymond James
VRSK Verisk Analytics
$187.52 /

-0.96 (-0.51%)

VRSK Verisk Analytics
$187.52 /

-0.96 (-0.51%)

Hot Stocks
Cabaletta Bio sees cash, cash equivalents to fund operations into Q4 of 2022 » 07:46
08/05/21
08/05
07:46
08/05/21
07:46
CABA

Cabaletta Bio

$7.00 /

-0.11 (-1.55%)

As of June 30, 2021,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CABA Cabaletta Bio
$7.00 /

-0.11 (-1.55%)

CABA Cabaletta Bio
$7.00 /

-0.11 (-1.55%)

06/29/21 Mizuho
Cabaletta Bio initiated with a Buy at Mizuho
03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
CABA Cabaletta Bio
$7.00 /

-0.11 (-1.55%)

Earnings
Revlon reports Q2 EPS ($1.01), consensus ($1.07) » 07:46
08/05/21
08/05
07:46
08/05/21
07:46
REV

Revlon

$10.87 /

-0.25 (-2.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REV Revlon
$10.87 /

-0.25 (-2.25%)

REV Revlon
$10.87 /

-0.25 (-2.25%)

REV Revlon
$10.87 /

-0.25 (-2.25%)

REV Revlon
$10.87 /

-0.25 (-2.25%)

Hot Stocks
The Buckle reports July net sales up 33.8% to $93.7M » 07:46
08/05/21
08/05
07:46
08/05/21
07:46
BKE

The Buckle

$40.59 /

-2.48 (-5.76%)

The Buckle announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKE The Buckle
$40.59 /

-2.48 (-5.76%)

BKE The Buckle
$40.59 /

-2.48 (-5.76%)

BKE The Buckle
$40.59 /

-2.48 (-5.76%)

Earnings
Sempra Energy reports Q2 adjusted EPS $1.63, consensus $1.61 » 07:46
08/05/21
08/05
07:46
08/05/21
07:46
SRE

Sempra Energy

$130.88 /

-1.105 (-0.84%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRE Sempra Energy
$130.88 /

-1.105 (-0.84%)

SRE Sempra Energy
$130.88 /

-1.105 (-0.84%)

07/07/21 Goldman Sachs
Sempra Energy downgraded to Buy from Conviction Buy at Goldman Sachs
06/30/21
Fly Intel: Top five analyst downgrades
06/30/21 BofA
Sempra Energy downgraded to Neutral from Buy at BofA
06/28/21 Mizuho
Sempra Energy price target raised to $154 from $148 at Mizuho
SRE Sempra Energy
$130.88 /

-1.105 (-0.84%)

SRE Sempra Energy
$130.88 /

-1.105 (-0.84%)

SRE Sempra Energy
$130.88 /

-1.105 (-0.84%)

Hot Stocks
Xoma expects cash to fund operations for multiple years » 07:45
08/05/21
08/05
07:45
08/05/21
07:45
XOMA

Xoma

$30.86 /

-1.34 (-4.16%)

On June 30, 2021, XOMA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOMA Xoma
$30.86 /

-1.34 (-4.16%)

XOMA Xoma
$30.86 /

-1.34 (-4.16%)

06/29/21 Aegis
Xoma initiated with a Buy at Aegis
01/19/21 H.C. Wainwright
Xoma price target raised to $56 from $30 at H.C. Wainwright
XOMA Xoma
$30.86 /

-1.34 (-4.16%)

Earnings
Houghton Mifflin reports Q2 cont-op EPS 2c, consensus (22c) » 07:45
08/05/21
08/05
07:45
08/05/21
07:45
HMHC

Houghton Mifflin

$11.70 /

+0.02 (+0.17%)

Reports Q2 revenue $309M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HMHC Houghton Mifflin
$11.70 /

+0.02 (+0.17%)

HMHC Houghton Mifflin
$11.70 /

+0.02 (+0.17%)

03/03/21 BMO Capital
Houghton Mifflin price target raised to $6 from $3 at BMO Capital
12/15/20 Citi
Houghton Mifflin price target raised to $3.45 from $3 at Citi
11/24/20 Citi
Houghton Mifflin price target raised to $3 from $2.50 at Citi
10/05/20 Citi
Houghton Mifflin upgraded to Neutral from Sell at Citi
HMHC Houghton Mifflin
$11.70 /

+0.02 (+0.17%)

HMHC Houghton Mifflin
$11.70 /

+0.02 (+0.17%)

HMHC Houghton Mifflin
$11.70 /

+0.02 (+0.17%)

Earnings
Xoma reports Q2 EPS (31c), consensus (35c) » 07:45
08/05/21
08/05
07:45
08/05/21
07:45
XOMA

Xoma

$30.86 /

-1.34 (-4.16%)

Reports Q2 revenue $0.9M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XOMA Xoma
$30.86 /

-1.34 (-4.16%)

XOMA Xoma
$30.86 /

-1.34 (-4.16%)

06/29/21 Aegis
Xoma initiated with a Buy at Aegis
01/19/21 H.C. Wainwright
Xoma price target raised to $56 from $30 at H.C. Wainwright
XOMA Xoma
$30.86 /

-1.34 (-4.16%)

Earnings
Cabaletta Bio reports Q2 EPS (45c), consensus (50c) » 07:45
08/05/21
08/05
07:45
08/05/21
07:45
CABA

Cabaletta Bio

$7.00 /

-0.11 (-1.55%)

"During the quarter,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CABA Cabaletta Bio
$7.00 /

-0.11 (-1.55%)

CABA Cabaletta Bio
$7.00 /

-0.11 (-1.55%)

06/29/21 Mizuho
Cabaletta Bio initiated with a Buy at Mizuho
03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
CABA Cabaletta Bio
$7.00 /

-0.11 (-1.55%)

Recommendations
Roku price target raised to $600 from $560 at DA Davidson » 07:44
08/05/21
08/05
07:44
08/05/21
07:44
ROKU

Roku

$420.63 /

+3.24 (+0.78%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

07:42 Today Benchmark
Benchmark would be buyers of Roku on post-earnings weakness
07:39 Today Stephens
Roku upgraded to Overweight from Equal Weight at Stephens
08/02/21 Morgan Stanley
Roku price target raised to $325 from $300 at Morgan Stanley
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

Hot Stocks
MultiPlan names Dale White as COO, says CFO David Redmond to retire at year end » 07:44
08/05/21
08/05
07:44
08/05/21
07:44
MPLN

MultiPlan

$7.72 /

-0.045 (-0.58%)

MultiPlan announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
05/14/21 B. Riley
MultiPlan quarter highlights industry positioning, says B. Riley
04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

Earnings
DigitalOcean sees FY21 revenue $419M-$423M, consensus $407.74M » 07:44
08/05/21
08/05
07:44
08/05/21
07:44
DOCN

DigitalOcean

$58.80 /

-2.13 (-3.50%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

07/23/21 Barclays
DigitalOcean price target raised to $64 from $58 at Barclays
04/19/21
Fly Intel: Top five analyst initiations
04/19/21 JPMorgan
DigitalOcean initiated with an Overweight at JPMorgan
04/19/21 Canaccord
Canaccord starts Digital Ocean as cloud adoption continues to accelerate
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

  • 24
    Mar
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

Earnings
NRG Energy reports Q2 EPS $4.40, consensus $1.46 » 07:43
08/05/21
08/05
07:43
08/05/21
07:43
NRG

NRG Energy

$41.74 /

+0.1 (+0.24%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

06/27/21 Goldman Sachs
NRG Energy upgraded to Conviction Buy from Buy at Goldman Sachs
06/21/21 Seaport Global
NRG Energy price target raised to $47 from $42 at Seaport Global
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Morgan Stanley
NRG Energy price target lowered to $51 from $59 at Morgan Stanley
NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

Earnings
Alico reports Q3 adjusted EPS 51c, one estimate 33c » 07:43
08/05/21
08/05
07:43
08/05/21
07:43
ALCO

Alico

$36.64 /

-0.6 (-1.61%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALCO Alico
$36.64 /

-0.6 (-1.61%)

ALCO Alico
$36.64 /

-0.6 (-1.61%)

12/21/20 Roth Capital
Alico initiated with a Buy at Roth Capital
ALCO Alico
$36.64 /

-0.6 (-1.61%)

Hot Stocks
Intellia Therapeutics expects cash to fund requirements beyond next 24 months » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
NTLA

Intellia Therapeutics

$147.54 /

+8.68 (+6.25%)

Intellia expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

06/30/21 Piper Sandler
Poseida Therapeutics being overlooked after Intellia data, says Piper Sandler
06/29/21 Cowen
Alnylam weakness a buying opportunity, says Cowen
06/29/21 Wedbush
Beam Therapeutics price target raised to $149 from $114 at Wedbush
06/29/21 Oppenheimer
Intellia Therapeutics price target raised to $125 from $73 at Oppenheimer
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

  • 30
    Jun
  • 02
    Dec
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

Recommendations
Benchmark would be buyers of Roku on post-earnings weakness » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
ROKU

Roku

/

+

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
/

+

ROKU Roku
/

+

07:39 Today Stephens
Roku upgraded to Overweight from Equal Weight at Stephens
08/02/21 Morgan Stanley
Roku price target raised to $325 from $300 at Morgan Stanley
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
07/08/21 Cannonball Research
Roku bear case 'not going to materialize,' says Cannonball Research
ROKU Roku
/

+

ROKU Roku
/

+

ROKU Roku
/

+

ROKU Roku
/

+

Earnings
DigitalOcean sees Q3 revenue $106M-$109M, consensus $104.12M » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
DOCN

DigitalOcean

$58.80 /

-2.13 (-3.50%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

07/23/21 Barclays
DigitalOcean price target raised to $64 from $58 at Barclays
04/19/21
Fly Intel: Top five analyst initiations
04/19/21 JPMorgan
DigitalOcean initiated with an Overweight at JPMorgan
04/19/21 Canaccord
Canaccord starts Digital Ocean as cloud adoption continues to accelerate
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

  • 24
    Mar
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

Downgrade
Nevro downgraded to Equal Weight at Wells Fargo » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

07:22 Today William Blair
Nevro downgraded to Market Perform on uncertainty at William Blair
06:49 Today Canaccord
Nevro downgraded to Hold from Buy at Canaccord
06:10 Today JMP Securities
Nevro price target lowered to $160 from $190 at JMP Securities
06:06 Today Piper Sandler
Nevro downgraded to Neutral from Overweight at Piper Sandler
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Earnings
Intellia Therapeutics reports Q2 EPS ($1.01), consensus (63c) » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
NTLA

Intellia Therapeutics

$147.54 /

+8.68 (+6.25%)

Reports Q2 revenue $6.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

06/30/21 Piper Sandler
Poseida Therapeutics being overlooked after Intellia data, says Piper Sandler
06/29/21 Cowen
Alnylam weakness a buying opportunity, says Cowen
06/29/21 Wedbush
Beam Therapeutics price target raised to $149 from $114 at Wedbush
06/29/21 Oppenheimer
Intellia Therapeutics price target raised to $125 from $73 at Oppenheimer
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

  • 30
    Jun
  • 02
    Dec
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

Earnings
Madrigal Pharmaceuticals reports Q2 EPS ($3.72), consensus ($3.59) » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
MDGL

Madrigal Pharmaceuticals

$85.02 /

-0.3 (-0.35%)

As of June 30, Madrigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

07/29/21 BTIG
Viking Therapeutics assumed with a Buy at BTIG
06/25/21 Piper Sandler
Madrigal showed 'compelling improvements' in MAESTRO-NASH, says Piper Sandler
06/23/21 Piper Sandler
Piper 'highly impressed' with Madrigal data in cirrhotic patients
05/24/21 Piper Sandler
Piper says Madrigal's MAESTRO-NASH outcome not impacted by NGM ALPINE data
MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

Downgrade
Fastly downgraded to Neutral from Buy at DA Davidson » 07:41
08/05/21
08/05
07:41
08/05/21
07:41
FSLY

Fastly

$44.50 /

-1.7 (-3.68%)

DA Davidson analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

07:24 Today William Blair
William Blair downgrades Fastly on 'uncertainty and unpredictability'
06:41 Today Citi
Fastly price target lowered to $33 from $46 at Citi
06:09 Today Piper Sandler
Fastly price target lowered to $32 from $45 at Piper Sandler
04:40 Today William Blair
Fastly downgraded to Market Perform from Outperform at William Blair
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

Hot Stocks
ACI Worldwide announces expanded multi-year strategic alliance with Microsoft » 07:41
08/05/21
08/05
07:41
08/05/21
07:41
ACIW

ACI Worldwide

$32.54 /

-1.02 (-3.04%)

, MSFT

Microsoft

$286.46 /

-0.68 (-0.24%)

ACI Worldwide (ACIW)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

05/06/21 BTIG
ACI Worldwide weakness due to lack of imminent sale signals, says BTIG
02/26/21 BTIG
ACI Worldwide sale 'still appears most likely outcome,' says BTIG
12/09/20 BTIG
ACI Worldwide price target raised to $46 from $39 at BTIG
12/08/20 Craig-Hallum
ACI Worldwide price target raised to $46 from $38 at Craig-Hallum
MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

07/28/21 JPMorgan
Microsoft price target raised to $310 from $300 at JPMorgan
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.